Recently, Dr. Yan Feng, the founder of LeadingTac, was selected as one of the "Pearl Leading Talent" in Pudong New Area in 2023 after passing the strict evaluation by the Talent Expert Group of Pudong New Area Committee for his targeted protein degradation project.

On December 6, 2023 Pudong International Talent Port Forum, with the theme of "Leadership, Gathering Momentum and Leap", was held at the Zhangjiang Science Hall. The first batch of "Pearl Program" tal

Following the U.S. FDA approval of LT-002 for the treatment of Hidradenitis Suppurativa (HS) and Atopic Dermatitis (AD) on May 24, 2023 (NCT06082323), Leadingtac received the clearance from the CDE of

Recently, Shanghai Municipal Science and Technology Commission announced the "List of Projects of Shanghai 2023 Technology Innovation Funding Program for Small and Medium-sized Enterprises (SMEs)". Af

Shanghai Leadingtac, a rapidly expanding biotechnology company, focusing on the development of protein degrader therapeutics, today announced the U.S. Food and Drug Administration (FDA) has cleared it

Zhangjiang Science Investment Family｜Leadingtac: Contributing to China's New Drug Development in ZhangjiangLooking back again, Yan Feng, founder of Vπ Zhangjiang Science Investment Ecological Fund

On April 7, 2023, KPMG China held the second "Biotechnology Innovation 50 Companies List Launch and Award Ceremony" in Beijing, Shanghai and Shenzhen offices, online and offline. After strict selectio

On March 28, 2023, Shanghai Leadingtac Pharmaceutical Co., Ltd. (hereinafter referred to as "Leadingtac Biotech") announced that it has officially submitted an IND clinical trial application to the U.

In October 2022, the Shanghai Science and Technology Commission awarded the honorary certificate of being selected as one of the "Shanghai Pujiang Talent Program Projects" for 2022.

On November 15, the first "Zhangjiang Life Science Industry Annual Emerging Talent" award was announced at the "Zhangjiang Life Science International Innovation Summit" in Pudong New Area, which focuses on recognizing emerging talents and enterprises that have made breakthroughs in "science, new discoveries, new inventions, new directions in industry and new ideas" since 2021. The award focuses on the new breakthroughs in "new discoveries, new inventions in technology, new directions in industry and new ideas in development" since 2021. Dr. Yan Feng was awarded as the "Zhangjiang Life and Health Industry Emerging Person of the Year".